Cargando…

Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents

Natural compounds provide precursors with various pharmacological activities and play an important role in discovering new chemical entities, including radiopharmaceuticals. In the development of new radiopharmaceuticals, iodine radioisotopes are widely used and interact with complex compounds inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurhidayah, Wiwit, Setyawati, Luthfi Utami, Daruwati, Isti, Gazzali, Amirah Mohd, Subroto, Toto, Muchtaridi, Muchtaridi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694974/
https://www.ncbi.nlm.nih.gov/pubmed/36432107
http://dx.doi.org/10.3390/molecules27228009
_version_ 1784837940347666432
author Nurhidayah, Wiwit
Setyawati, Luthfi Utami
Daruwati, Isti
Gazzali, Amirah Mohd
Subroto, Toto
Muchtaridi, Muchtaridi
author_facet Nurhidayah, Wiwit
Setyawati, Luthfi Utami
Daruwati, Isti
Gazzali, Amirah Mohd
Subroto, Toto
Muchtaridi, Muchtaridi
author_sort Nurhidayah, Wiwit
collection PubMed
description Natural compounds provide precursors with various pharmacological activities and play an important role in discovering new chemical entities, including radiopharmaceuticals. In the development of new radiopharmaceuticals, iodine radioisotopes are widely used and interact with complex compounds including natural products. However, the development of radiopharmaceuticals from natural compounds with iodine radioisotopes has not been widely explored. This review summarizes the development of radiopharmaceuticals from natural compounds using iodine radioisotopes in the last 10 years, as well as discusses the challenges and strategies to improve future discovery of radiopharmaceuticals from natural resources. Literature research was conducted via PubMed, from which 32 research articles related to the development of natural compounds labeled with iodine radioisotopes were reported. From the literature, the challenges in developing radiopharmaceuticals from natural compounds were the purity and biodistribution. Despite the challenges, the development of radiopharmaceuticals from natural compounds is a golden opportunity for nuclear medicine advancement.
format Online
Article
Text
id pubmed-9694974
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96949742022-11-26 Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents Nurhidayah, Wiwit Setyawati, Luthfi Utami Daruwati, Isti Gazzali, Amirah Mohd Subroto, Toto Muchtaridi, Muchtaridi Molecules Review Natural compounds provide precursors with various pharmacological activities and play an important role in discovering new chemical entities, including radiopharmaceuticals. In the development of new radiopharmaceuticals, iodine radioisotopes are widely used and interact with complex compounds including natural products. However, the development of radiopharmaceuticals from natural compounds with iodine radioisotopes has not been widely explored. This review summarizes the development of radiopharmaceuticals from natural compounds using iodine radioisotopes in the last 10 years, as well as discusses the challenges and strategies to improve future discovery of radiopharmaceuticals from natural resources. Literature research was conducted via PubMed, from which 32 research articles related to the development of natural compounds labeled with iodine radioisotopes were reported. From the literature, the challenges in developing radiopharmaceuticals from natural compounds were the purity and biodistribution. Despite the challenges, the development of radiopharmaceuticals from natural compounds is a golden opportunity for nuclear medicine advancement. MDPI 2022-11-18 /pmc/articles/PMC9694974/ /pubmed/36432107 http://dx.doi.org/10.3390/molecules27228009 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nurhidayah, Wiwit
Setyawati, Luthfi Utami
Daruwati, Isti
Gazzali, Amirah Mohd
Subroto, Toto
Muchtaridi, Muchtaridi
Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title_full Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title_fullStr Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title_full_unstemmed Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title_short Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
title_sort future prospective of radiopharmaceuticals from natural compounds using iodine radioisotopes as theranostic agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694974/
https://www.ncbi.nlm.nih.gov/pubmed/36432107
http://dx.doi.org/10.3390/molecules27228009
work_keys_str_mv AT nurhidayahwiwit futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents
AT setyawatiluthfiutami futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents
AT daruwatiisti futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents
AT gazzaliamirahmohd futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents
AT subrotototo futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents
AT muchtaridimuchtaridi futureprospectiveofradiopharmaceuticalsfromnaturalcompoundsusingiodineradioisotopesastheranosticagents